Related Experiment Videos
Cytotoxic and cancerostatic effect of 1,4-dithiaanthraquinone-2,3-dicarbonitrile
Abstract:
1,4-Dithiaanthraquinone-2,3-dicarbonitrile (DTA) has been found to exert a considerable cytostatic effect especially on some of the investigated types of eukaryotic cells, concretely on the HeLa cells, moulds, yeasts, protozoa and algae. In cells of the Ehrlich ascites carcinoma (EAC) DTA after a short exposition causes a parallel inhibition of incorporation of 14C-adenine and 14C-valine, in proportion to its rising concentration. The inhibition of biosynthetic processes thus made manifest, is probably a consequence of the primary DTA intervention into the energy metabolism of EAC cells, particularly in glycolysis. The effect of DTA in concentrations capable of bringing about full inhibition of glucose consumption or lactate formation in EAC cells also results in a loss of their transplantability. On the other hand, DTA also exerts a cancerostatic effect on the Ehrlich ascites carcinoma in mice.
Insights
1,4-Dithiaanthraquinone-2,3-dicarbonitrile (DTA) shows significant cytostatic effects on eukaryotic cells, including cancer cells. DTA inhibits biosynthesis and energy metabolism, demonstrating cancerostatic potential against Ehrlich ascites carcinoma in mice.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Eukaryotic cells, including HeLa cells, fungi, protozoa, and algae, are susceptible to cytostatic agents.
- Ehrlich ascites carcinoma (EAC) is a model for studying cancer cell metabolism and drug response.
Purpose of the Study:
- To investigate the cytostatic and cancerostatic effects of 1,4-Dithiaanthraquinone-2,3-dicarbonitrile (DTA).
- To elucidate the mechanism of DTA's action on cancer cell biosynthesis and energy metabolism.
Main Methods:
- Assessing the cytostatic effects of DTA on various eukaryotic cell types.
- Measuring the incorporation of 14C-adenine and 14C-valine in EAC cells exposed to DTA.
- Analyzing the impact of DTA on glucose consumption and lactate formation in EAC cells.
- Evaluating the transplantability and cancerostatic effect of DTA in a murine EAC model.
Main Results:
- DTA demonstrated significant cytostatic effects on HeLa cells, moulds, yeasts, protozoa, and algae.
- DTA inhibited 14C-adenine and 14C-valine incorporation in EAC cells in a dose-dependent manner.
- DTA interfered with EAC cell energy metabolism, specifically glycolysis, inhibiting glucose consumption and lactate production.
- DTA treatment led to a loss of EAC cell transplantability and exhibited a cancerostatic effect in mice.
Conclusions:
- 1,4-Dithiaanthraquinone-2,3-dicarbonitrile (DTA) exhibits potent cytostatic and cancerostatic properties.
- DTA's mechanism involves the inhibition of essential biosynthetic pathways and energy metabolism, particularly glycolysis.
- DTA represents a potential therapeutic agent for Ehrlich ascites carcinoma.